Our results indicate that it is possible to overcome these glucagon inhibitory signals and to alleviate hyperinsulinemic hypoglycemia by amplifying glucagon signaling downstream of the initiating glucagon receptor binding. This evidence concerns the gene GCGR and hyperinsulinemic hypoglycemia.